Westlake Village biotech company MannKind made its debut on the Russell 3000 Index on June 26, according to an announcement by the company. The Russell 3000 Index is a market-capitalization weighted compilation of U.S. stocks tracked by The Financial Times and the London Stock Exchange, or FTSE, and is reconstituted every year in June. MannKind…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
